Malignant neoplasm of prostate
|
0.400 |
Biomarker
|
disease |
CTD_human |
The long tail of oncogenic drivers in prostate cancer.
|
29610475 |
2018 |
Prostatic Neoplasms
|
0.350 |
Biomarker
|
group |
CTD_human |
The long tail of oncogenic drivers in prostate cancer.
|
29610475 |
2018 |
melanoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma.
|
29426936 |
2018 |
Lymphatic Metastasis
|
0.320 |
Biomarker
|
disease |
CTD_human |
Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma.
|
29426936 |
2018 |
Hereditary Paraganglioma-Pheochromocytoma Syndrome
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.
|
26700204 |
2016 |
Tibia, Bowing of, with Pseudarthrosis and Pectus Excavatum
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations Preventing Regulated Exon Skipping in MET Cause Osteofibrous Dysplasia.
|
26637977 |
2015 |
OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO
|
0.300 |
GermlineCausalMutation
|
phenotype |
ORPHANET |
Mutations Preventing Regulated Exon Skipping in MET Cause Osteofibrous Dysplasia.
|
26637977 |
2015 |
Papillary Renal Cell Carcinoma
|
0.800 |
SomaticCausalMutation
|
disease |
ORPHANET |
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
|
26536169 |
2016 |
DEAFNESS, AUTOSOMAL RECESSIVE 97
|
0.510 |
GeneticVariation
|
disease |
UNIPROT |
A mutation of MET, encoding hepatocyte growth factor receptor, is associated with human DFNB97 hearing loss.
|
25941349 |
2015 |
Nonsyndromic Deafness
|
0.300 |
Biomarker
|
disease |
CLINGEN |
A mutation of MET, encoding hepatocyte growth factor receptor, is associated with human DFNB97 hearing loss.
|
25941349 |
2015 |
Malignant mesothelioma
|
0.340 |
Biomarker
|
disease |
CTD_human |
MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion.
|
25756049 |
2015 |
Papillary Renal Cell Carcinoma
|
0.800 |
Biomarker
|
disease |
CTD_human |
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.
|
25401301 |
2015 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.600 |
Biomarker
|
disease |
CTD_human |
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.
|
25401301 |
2015 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.
|
25401301 |
2015 |
Chromophobe Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.
|
25401301 |
2015 |
Sarcomatoid Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.
|
25401301 |
2015 |
Collecting Duct Carcinoma of the Kidney
|
0.300 |
Biomarker
|
disease |
CTD_human |
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.
|
25401301 |
2015 |
Non-Small Cell Lung Carcinoma
|
0.600 |
Biomarker
|
disease |
CTD_human |
KRAS mutation status is associated with enhanced dependency on folate metabolism pathways in non-small cell lung cancer cells.
|
24688052 |
2014 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Some of these EGFR-mutated PDXs do not respond to erlotinib: LU1868 containing L858R/T790M mutations, and LU0858 having L858R mutation as well as c-MET gene amplification, both squamous cell carcinoma (SCC).
|
22948846 |
2013 |
Hepatitis, Chronic
|
0.300 |
Biomarker
|
disease |
CTD_human |
COMMD1-deficient dogs accumulate copper in hepatocytes and provide a good model for chronic hepatitis and fibrosis.
|
22879914 |
2012 |
Chronic Persistent Hepatitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
COMMD1-deficient dogs accumulate copper in hepatocytes and provide a good model for chronic hepatitis and fibrosis.
|
22879914 |
2012 |
Chronic active hepatitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
COMMD1-deficient dogs accumulate copper in hepatocytes and provide a good model for chronic hepatitis and fibrosis.
|
22879914 |
2012 |
Cryptogenic Chronic Hepatitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
COMMD1-deficient dogs accumulate copper in hepatocytes and provide a good model for chronic hepatitis and fibrosis.
|
22879914 |
2012 |
Copper-Overload Cirrhosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
COMMD1-deficient dogs accumulate copper in hepatocytes and provide a good model for chronic hepatitis and fibrosis.
|
22879914 |
2012 |
Non-Small Cell Lung Carcinoma
|
0.600 |
Biomarker
|
disease |
CTD_human |
Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS.
|
22787409 |
2012 |